Betahistine - Cyathus Exquirere Pharmaforschungs Gmbh

Drug Profile

Betahistine - Cyathus Exquirere Pharmaforschungs Gmbh

Alternative Names: AcuVer; Akuver; Bestin; Betahistine DiHCL 8mg/pump stroke, oral solution; Betahistine dihydrochloride oral solution; Betahistine oral solution; Betahistine.2HCL 8mg/pumpstroke oral solution; Marac; Marak; Neatin

Latest Information Update: 15 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cyathus Exquirere
  • Class Pyridines; Small molecules
  • Mechanism of Action Histamine H1 receptor agonists; Histamine H3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Vertigo

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top